Showing results (61-70 of 98) with videos related to
Sort By:
Pageof 10
Annals of Palliative Medicine|May 15, 2015
Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapyLeigha Rowbottom, Jordan Stinson, Rachel McDonald, et al.The Oncologist|November 7, 2015
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate CancerUrban Emmenegger, Christopher M Booth, Scott Berry, et al.Molecular Cancer Therapeutics|August 3, 2007
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in miceUrban Emmenegger, Yuval Shaked, Shan Man, et al.Cancers|October 16, 2024
Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi ConsensusKori Leblanc, Scott J Edwards, George Dranitsaris, et al.British Journal of Cancer|January 6, 2017
Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growthKarla Parra, Paloma Valenzuela, Natzidielly Lerma, et al.Cancer Research|October 23, 2013
miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1Xiaoyong Huang, Samira Taeb, Sahar Jahangiri, et al.Journal of Bone Oncology|June 24, 2016
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)Ricardo Fernandes, Peter Siegel, Svetlana Komarova, et al.Journal of Geriatric Oncology|July 8, 2023
Daily physical activity monitoring in older adults with metastatic prostate cancer on active treatment: Feasibility and associations with toxicityGregory Feng, Milothy Parthipan, Henriette Breunis, et al.Journal of Palliative Medicine|April 23, 2010
A multicenter assessment of the adequacy of cancer pain treatment using the pain management indexGunita Mitera, Alysa Fairchild, Carlo DeAngelis, et al.Current Oncology (Toronto, Ont.)|March 27, 2024
177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical PracticeKim N Chi, Steven M Yip, Glenn Bauman, et al.Pageof 10